Document is current
Any future updates will be listed below
-
Authors
Owen, Dwight H. https://orcid.org/0000-0002-6598-4886
Wu, Ruohan
Wei, Lai
Dikov, Mikhail
Suman, Shankar
Su, Po-Lan
Amann, Joseph
Guan, Shuxiao
Spakowicz, Daniel
Schweitzer, Catherine
Pilcher, Carly
Smith, Michael B.
Ferguson, Sarah
Palomino, Julio Castro
Pérez, Santiago Figueroa
Bertino, Erin M.
Shields, Peter G.
He, Kai
Presley, Carolyn J.
Otterson, Gregory A.
Carson, William E.
Carbone, David P.
-
Funding
Funding for this research was provided by:
National Institutes of Health (P30CA016058)
Palobiofarma Inc.
The Ohio State University Comprehensive Cancer Center (OSUCCC) Intramural Research Program (Pelotonia)
- License Information
-
More Information
Article History
Received: 22 July 2025
Accepted: 17 October 2025
First Online: 3 December 2025
Declarations
:
: The study was approved by The Ohio State University Institutional Review Board (#2018C0019).
: All study participants provided written informed consent prior to treatment initiation.
: DHO, DPC, and MD received research funding from Palobiofarma. JC and SP are employees of Palobiofarma. RW, LW, SS, PLS, JA, SG, DS, CS, CP, MBS, SF, EMB, PGS, KH, CJP, and GAO have no relevant financial or non-financial interests to disclose.
